NOVO.B.DK

289.85

+0.36%↑

GMAB.DK

1,718.5

-0.72%↓

HLUNB.DK

42.58

+1.28%↑

ZEAL.DK

324.8

+1.06%↑

AMBUB.DK

66.95

+0.22%↑

NOVO.B.DK

289.85

+0.36%↑

GMAB.DK

1,718.5

-0.72%↓

HLUNB.DK

42.58

+1.28%↑

ZEAL.DK

324.8

+1.06%↑

AMBUB.DK

66.95

+0.22%↑

NOVO.B.DK

289.85

+0.36%↑

GMAB.DK

1,718.5

-0.72%↓

HLUNB.DK

42.58

+1.28%↑

ZEAL.DK

324.8

+1.06%↑

AMBUB.DK

66.95

+0.22%↑

NOVO.B.DK

289.85

+0.36%↑

GMAB.DK

1,718.5

-0.72%↓

HLUNB.DK

42.58

+1.28%↑

ZEAL.DK

324.8

+1.06%↑

AMBUB.DK

66.95

+0.22%↑

NOVO.B.DK

289.85

+0.36%↑

GMAB.DK

1,718.5

-0.72%↓

HLUNB.DK

42.58

+1.28%↑

ZEAL.DK

324.8

+1.06%↑

AMBUB.DK

66.95

+0.22%↑

Accueil・Liste d'Actions・Coloplast A-S (Class B)

Coloplast A-S (Class B)

Fermé

404 0.1

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

403.6

Max

408

Chiffres clés
By Trading Economics
Revenu	-2.4B -971M
Ventes	41M 7.1B
P/E Moyenne du Secteur	43.348 50.102
BPA	-0.16
Rendement du dividende	5.7
Marge bénéficiaire	-13.707
Employés	17,083
EBITDA	2.8B 5.1B

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	+11.86% upside

Dividendes
By Dow Jones
Rendement du dividende Moyenne du Secteur	5.70% 2.33%

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	766M 91B
Ouverture précédente	403.9
Clôture précédente	404

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 mai 2026, 21:33 UTC

Résultats

Correction to Salesforce 1Q Sales, Profit Rise Article

27 mai 2026, 21:00 UTC

Acquisitions, Fusions, Rachats

HCA Healthcare Agrees to Buy The College of Health Care Professions

27 mai 2026, 20:18 UTC

Résultats

Salesforce 1Q Sales, Profit Rise Amid Agentforce Efforts

27 mai 2026, 23:49 UTC

Market Talk

Nikkei Might Decline Amid Uncertainty Over Potential U.S.-Iran Peace Deal -- Market Talk

27 mai 2026, 23:39 UTC

Market Talk

Congo Copper, Cobalt Mining Not yet Seen Affected by Ebola Outbreak -- Market Talk

27 mai 2026, 23:34 UTC

Market Talk

Infratil's Longroad Energy Considers Data-Center Strategy -- Market Talk

27 mai 2026, 23:34 UTC

Market Talk

Global Equities Roundup: Market Talk

27 mai 2026, 23:08 UTC

Market Talk

Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk

27 mai 2026, 22:21 UTC

Market Talk

Salesforce Lays Out AI Monetization Strategy -- Market Talk

27 mai 2026, 21:29 UTC

Actions en Tendance

Stocks to Watch: Marvell Technology, PDD, Zscaler -- WSJ

27 mai 2026, 21:08 UTC

Résultats

Marvell's Data-Center Boom Powers Earnings Beat. Its Stock Surges. -- Barrons.com

27 mai 2026, 21:02 UTC

Résultats

Salesforce Stock Slides on Mixed Results. CFO Touts New Pricing Model. -- Barrons.com

27 mai 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

What to Know About Pasqal, the Quantum Start-Up Going Public Soon -- Barrons.com

27 mai 2026, 20:55 UTC

Résultats

Snowflake Stock Jumps 34%. How Amazon and an Earnings Beat Are Fueling the Gains. -- Barrons.com

27 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

27 mai 2026, 20:48 UTC

Résultats

Marvell's Data-Center Boom Powers Earnings Beat -- and a Big Stock Surge -- Barrons.com

27 mai 2026, 20:45 UTC

Résultats

Marvell Stock Jumps on Earnings. Data-Center Revenue Is Still Booming. -- Barrons.com

27 mai 2026, 20:34 UTC

Acquisitions, Fusions, Rachats

Webster Financial Stockholders Approve Sale to Banco Santander

27 mai 2026, 20:32 UTC

Résultats

Acquisitions, Fusions, Rachats

Synopsys Shares Fall Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

27 mai 2026, 20:32 UTC

Acquisitions, Fusions, Rachats

HCA Healthcare to Acquire The College of Health Care Professions for Undisclosed Terms >HCA

27 mai 2026, 20:32 UTC

Acquisitions, Fusions, Rachats

HCA Healthcare: Eric Bing Will Continue to Lead CHCP as Chancellor and CEO >HCA

27 mai 2026, 20:30 UTC

Résultats

Snowflake Beats Expectations and Expands AWS Ties Amid Software Sector Turmoil -- Barrons.com

27 mai 2026, 20:30 UTC

Acquisitions, Fusions, Rachats

HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions >HCA

27 mai 2026, 20:22 UTC

Résultats

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 mai 2026, 20:16 UTC

Résultats

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 mai 2026, 20:13 UTC

Résultats

Synopsys Sees 3Q Adj EPS $3.63-Adj EPS $3.69 >SNPS

27 mai 2026, 20:13 UTC

Résultats

Marvell Revenue Beats Estimates. The Stock Rises. -- Barrons.com

27 mai 2026, 20:13 UTC

Résultats

Synopsys Sees FY Adj EPS $14.72-Adj EPS $14.80 >SNPS

27 mai 2026, 20:12 UTC

Résultats

Synopsys Sees FY EPS $2.49-EPS $2.91 >SNPS

27 mai 2026, 20:12 UTC

Résultats

Synopsys Sees 3Q EPS 84c-EPS 98c >SNPS

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK 11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.